Kyntra Bio (KYNB) Non-Current Assets (2016 - 2025)
Historic Non-Current Assets for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to $3.6 million.
- Kyntra Bio's Non-Current Assets fell 8194.75% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.0 million, marking a year-over-year decrease of 8093.09%. This contributed to the annual value of $18.0 million for FY2024, which is 8041.1% down from last year.
- As of Q3 2025, Kyntra Bio's Non-Current Assets stood at $3.6 million, which was down 8194.75% from $15.7 million recorded in Q2 2025.
- In the past 5 years, Kyntra Bio's Non-Current Assets ranged from a high of $299.8 million in Q4 2021 and a low of $3.6 million during Q3 2025
- In the last 5 years, Kyntra Bio's Non-Current Assets had a median value of $103.8 million in 2023 and averaged $119.6 million.
- In the last 5 years, Kyntra Bio's Non-Current Assets skyrocketed by 31790.32% in 2021 and then tumbled by 8194.75% in 2025.
- Over the past 5 years, Kyntra Bio's Non-Current Assets (Quarter) stood at $299.8 million in 2021, then tumbled by 60.88% to $117.3 million in 2022, then fell by 21.57% to $92.0 million in 2023, then crashed by 80.41% to $18.0 million in 2024, then crashed by 80.07% to $3.6 million in 2025.
- Its Non-Current Assets was $3.6 million in Q3 2025, compared to $15.7 million in Q2 2025 and $16.7 million in Q1 2025.